Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Meridian Bioscience, Inc. VIVO |
The Vanguard Group | 4,970,105 11.340% |
93,163 (+1.91%) |
Filing History |
| 2023-02-03 2:06 pm Sale |
2023-01-31 | 13D | Meridian Bioscience, Inc. VIVO |
Magnetar Financial LLC | 0 0.000% |
-2,204,418 (Position Closed) |
Filing History |
| 2023-01-31 11:06 am Sale |
2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
ROYCE & ASSOCIATES LLC | 169,512 0.390% |
-2,026,122 (-92.28%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
BLACKROCK INC BLK |
7,557,772 17.200% |
0 (Unchanged) |
Filing History |
| 2023-01-20 5:17 pm Purchase |
2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
BLACKROCK INC BLK |
7,557,772 17.200% |
151,847 (+2.05%) |
Filing History |
| 2023-01-10 5:22 pm Purchase |
2023-01-06 | 13D | Meridian Bioscience, Inc. VIVO |
Magnetar Financial LLC | 2,204,418 5.020% |
2,204,418 (New Position) |
Filing History |
| 2022-12-02 2:16 pm Sale |
2022-11-30 | 13D | Meridian Bioscience, Inc. VIVO |
Magnetar Financial LLC | 2,173,294 4.960% |
-87,394 (-3.87%) |
Filing History |
| 2022-11-02 7:48 pm Purchase |
2022-10-24 | 13D | Meridian Bioscience, Inc. VIVO |
Magnetar Financial LLC | 2,260,688 5.170% |
12,363 (+0.55%) |
Filing History |
| 2022-10-28 4:30 pm Sale |
2022-10-27 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 1,910,919 4.400% |
-495,639 (-20.60%) |
Filing History |
| 2022-10-18 4:45 pm Sale |
2022-10-14 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 2,406,558 5.500% |
-494,628 (-17.05%) |
Filing History |
| 2022-09-19 4:51 pm Sale |
2022-09-15 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 2,901,186 6.600% |
-639,355 (-18.06%) |
Filing History |
| 2022-09-19 12:23 pm Purchase |
2022-09-07 | 13D | Meridian Bioscience, Inc. VIVO |
Magnetar Financial LLC | 2,248,325 5.140% |
2,248,325 (New Position) |
Filing History |
| 2022-09-07 4:36 pm Sale |
2022-09-02 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 3,540,541 8.100% |
-781,428 (-18.08%) |
Filing History |
| 2022-08-10 10:22 am Sale |
2022-07-31 | 13G | Meridian Bioscience, Inc. VIVO |
EARNEST PARTNERS LLC | 138,110 0.300% |
-3,586,200 (-96.29%) |
Filing History |
| 2022-02-11 4:17 pm Sale |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
Flynn James E | 1,125,083 2.590% |
-1,035,917 (-47.94%) |
Filing History |
| 2022-02-10 6:20 pm Sale |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
Renaissance Technologies LLC | 1,913,304 4.400% |
-400,560 (-17.31%) |
Filing History |
| 2022-02-10 08:53 am Sale |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
EARNEST PARTNERS LLC | 3,724,310 8.600% |
-617,524 (-14.22%) |
Filing History |
| 2022-02-10 08:27 am Purchase |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
The Vanguard Group | 4,876,942 11.210% |
119,227 (+2.51%) |
Filing History |
| 2022-02-04 5:09 pm Purchase |
2022-01-25 | 13D | Meridian Bioscience, Inc. VIVO |
Impactive Capital LP | 4,321,969 9.900% |
4,321,969 (New Position) |
Filing History |
| 2022-01-27 11:00 am Unchanged |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
BLACKROCK INC BLK |
7,405,925 17.000% |
0 (Unchanged) |
Filing History |